BAUSCH HEALTH COMPAN
BHC
 Delayed - 06/23 04:10:00 pm |
|
| 29.08USD | -0.48% |
Upcoming events on BAUSCH HEALTH COMPANIES INC.
| 08/10/21 | Interim 2021 Earnings Release (Projected) |
| 11/09/21 | Q3 2021 Earnings Release (Projected) |
| 02/23/22 | FY 2021 Earnings Release (Projected) |
| 05/10/22 | Q1 2022 Earnings Release (Projected) |
Past events on BAUSCH HEALTH COMPANIES INC.
| 06/02/21 | 11:00am | Jefferies Healthcare Conference |
| 05/25/21 | 12:45pm | Barclays High Yield Bond & Syndicated Loan Conference |
| 05/21/21 | Digestive Disease Week Conference |
| 05/17/21 | 01:10pm | Goldman Sachs Leveraged Finance Conference |
Upcoming sector events for BAUSCH HEALTH COMPANIES INC.
| 06/23/21 | 08:00am | JOHNSON & JOHNSON : Business Update Call |
| 06/23/21 | NOVARTIS AG : Guggenheim Biopharma's Next Decade Conference |
| 07/21/21 | 08:30am | JOHNSON & JOHNSON : Interim 2021 Earnings Call |
| 07/21/21 | 06:45am | JOHNSON & JOHNSON : Interim 2021 Earnings Release |
Past sector events for BAUSCH HEALTH COMPANIES INC.
| 06/22/21 | 08:30am | NOVARTIS AG : LNP023 Update Call |
| 06/22/21 | 02:30am | ROCHE HOLDING AG : European Academy of Neurology Meeting - OS4004 |
| 06/21/21 | 08:00am | ROCHE HOLDING AG : European Academy of Neurology Meeting - Engaging the Alzheimer’s disease (AD) CareRing caregiver com |
| 06/21/21 | 08:00am | ROCHE HOLDING AG : European Academy of Neurology Meeting - EPO323 |
Annual results
| Fiscal Period : December | 2020 | 2021 | ||||||||||||
| Sales M $ |
Released Forecast Spread | 8 027 7 968 0,74% | 8 611 | |||||||||||
| Operating income (EBITDA) M $ |
Released Forecast Spread | 3 294 3 257 1,1% | 3 450 | |||||||||||
| Operating profit (EBIT) M $ |
Released Forecast Spread | 2 959 3 003 -1,5% | 3 137 | |||||||||||
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -934 -577 -62% | -679 | |||||||||||
| Net income M $ |
Released Forecast Spread | -560 -529 -5,9% | -719 | |||||||||||
| EPS $ |
Released Forecast Spread | -1,58 -1,47 -7,5% | -1,92 | |||||||||||
| Announcement Date | 02/24/2021 | - | ||||||||||||
| ||||||||||||||
Previous year
Quarterly / Semiannualy publications
| Fiscal Period : December | 2021 Q1 | 2021 Q2 | ||||||||||||||||||||||||||
| Sales M $ |
Released Forecast Spread | 2 027 2 061 -1,6% | 2 115 | |||||||||||||||||||||||||
| Operating income (EBITDA) M $ |
Released Forecast Spread | 852 817 4,3% | 803 | |||||||||||||||||||||||||
| Operating profit (EBIT) M $ |
Released Forecast Spread | 735 729 0,84% | 754 | |||||||||||||||||||||||||
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -591 -64,0 -824% | -95,0 | |||||||||||||||||||||||||
| Net income M $ |
Released Forecast Spread | -610 -58,4 -944% | -131 | |||||||||||||||||||||||||
| EPS $ |
Released Forecast Spread | -1,71 -0,16 -947% | -0,27 | |||||||||||||||||||||||||
| Announcement Date | 05/04/2021 | - | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
